About Sagmarks Private Limited
Data last updated:
Sagmarks Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the healthtech and medical tech solutions segment of the healthcare sector. It was incorporated on 19 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U25209UP2016PTC087202. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manju Agarwal and Varma Khushbu Rajeshbhai.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at J – 14 Rdc, Ghaziabad, Uttar Pradesh, India – 201001.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.82 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹9,168 (net margin 2.4%) and EBITDA of ₹12,389 (EBITDA margin 3.2%). Revenue has declined at a compounded annual rate (CAGR) of 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sagmarks.in.
Company details
Contact details
Sagmarks Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its website is sagmarks.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressJ – 14 Rdc, Ghaziabad, Uttar Pradesh, India – 201001
- IndustryHealthcare, HealthTech & Medical Tech Solutions
To see the full contact details of Sagmarks Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sagmarks is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Sagmarks Private Limited, buy the company report.
Financials of Sagmarks Private Limited
FY 2024 filings availableSagmarks Private Limited reported revenue of ₹3.82 Lakh (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 1% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12,389 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9,168 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sagmarks Private Limited, buy the company report.
Board of directors of Sagmarks Private Limited
Sagmarks has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manju Agarwal | Director | 19 Oct 2016 | 10 Years 0 Months | Current |
| Varma Khushbu Rajeshbhai Also directs: Eswasthalya Healthcare Private Limited | Director | 19 Oct 2016 | 10 Years 0 Months | Current |
Auditor
Sagmarks Private Limited is audited by K S V & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K S V & CO | FY 2021 | 012758C |
Shareholding
The shareholding of Sagmarks Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sagmarks Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sagmarks Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sagmarks Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sagmarks has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sagmarks Private Limited, buy the company report.
Recent activity
Sagmarks Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Priyam Garg ceased to be Director on 09 Jan 2017.
Frequently asked questions
Sagmarks is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in healthtech and medical tech solutions, within the healthcare industry. It was incorporated on 19 October 2016 (10+ years old) and is registered under CIN U25209UP2016PTC087202.
Sagmarks has 2 current directors:
- Manju Agarwal - Director
- Varma Khushbu Rajeshbhai - Director
The latest financial statements of Sagmarks on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
No. Sagmarks has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Sagmarks is U25209UP2016PTC087202. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sagmarks was incorporated on 19 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
Priyam Garg ceased to be Director on 09 Jan 2017. Manju Agarwal was appointed as Director on 19 Oct 2016. Varma Khushbu Rajeshbhai was appointed as Director on 19 Oct 2016.
Sagmarks can be reached through the website sagmarks.in. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The registered office of Sagmarks is at J – 14 Rdc, Ghaziabad, Uttar Pradesh, India – 201001.
Sagmarks operates in the healthcare industry, in the healthtech and medical tech solutions segment.